title: Routine statin treatment after acute coronary syndromes?
authors.forename: Monica
authors.initials: M
authors.lastname: Acevedo
authors.forename: Dennis L
authors.initials: DL
authors.lastname: Sprecher
authors.forename: Michael S
authors.initials: MS
authors.lastname: Lauer
authors.forename: Gary
authors.initials: G
authors.lastname: Francis
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D010351:Patient Discharge; D017410:Practice Guidelines as Topic; D011758:Pyrroles / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013577:Syndrome; D015912:Thrombolytic Therapy; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin